From Bonini S, Lambiase A, Rama P, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125(9):1332–1343.
File Size:
163 KB
Cornea/External Disease
a. Slit-lamp photographs and fluorescein staining images from a patient after 8 weeks of treatment in the first phase 2 clinical trial. b. Dimensional changes from baseline for each of the 3 arms at week 4 and week 8 of treatment.